PSLY.com

PSLY.com was a healthcare-oriented public company vehicle formed in 2022 to acquire Ei.Ventures and Mycotopia Therapies and create a combined psychedelics and mental wellness company. The proposed business was focused on psychoactive compounds, fungi-derived products, nutraceuticals, and technology-enabled wellness offerings rather than a mature clinical-stage drug pipeline. SEC materials described the company as seeking a Nasdaq listing under the symbol PSLY, but the merger with Ei.Ventures and Mycotopia was later terminated. Based on the available evidence, PSLY.com appears to have been an early-stage, transaction-driven entity rather than an operating biotech with disclosed clinical assets, and it does not appear to be active today.